Trial NCT00415246

View at ClinicalTrials.gov 
Org. Study IDs: 2-55-52014-145
Secondary IDs: 2006-001511-30

Last trial update was posted on 2019-11-22

MeSH Interventions

Triptorelin Pamoate

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Prostate Cancer

Stopping Reasons

The preliminary data do not support the expected sustainable blood levels of triptorelin for a duration of 4 months in all patients.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID